Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Neal Insider Profile
4 Followers
James Neal, CEO, Director at Xoma, holds 33.38K shares in Xoma (Ticker: XOMA), holds 10.92K shares in Palisade Bio (Ticker: PALI), holds 14.41K shares in Processa Pharmaceuticals (Ticker: PCSA).
Profitable Transactions
13 out of 14 Profitable Transactions
Average Return
+52.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Neal holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Neal
James Neal's Trading History
Xoma
Jul 18, 2022
CEO, Director
Uninformative Sell
746.08K
$809.51K
Palisade Bio
―
Director
―
$72.07K
Processa Pharmaceuticals
Jul 24, 2023
Director
Uninformative Buy
―
$23.92K
Peak Bio
―
Director
―
―
List of latest transactions for each holding click on a transaction to see James Neal's performance on stock
You May Also Like
James Neal insider profile FAQ
What is the percentage of profitable transactions made by James Neal?
The percentage of profitable transactions made by James Neal is 93%.
What is the average return per transaction made by James Neal?
The average return per transaction made by James Neal is 52.70%.
What stocks does James Neal hold?
James Neal holds: XOMA, PALI, PCSA, PKBO stocks.
What was James Neal’s latest transaction?
James Neal latest transaction was an Uninformative Sell of $746.08K.
What was James Neal's most profitable transaction?
James Neal’s most profitable transaction was an Informative Buy of XOMA stock on December 21, 2018. The return on the trade was 116.00%.
What is James Neal's role in Xoma?
James Neal's role in Xoma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.